godfather of surgery

Chapter 1237 Six People?
Yang Ping's reaction surprised the leaders and Dean Xia. He spoke of such an important matter as if it were an extremely ordinary thing, without any emotional fluctuation.

He actually said that a few people would be enough to research these key technologies. The leader thought for a moment, shook Yang Ping's hand, and said nothing more. The ideas of a genius are hard to fathom, so he could only give his full support.

After Yang Ping left, the leader looked at Dean Xia, and Dean Xia looked at the leader. The two were quite embarrassed and didn't know what to say.

Dean Xia broke the deadlock first: "I—I—I'm used to it. Anyway, I won't ask or care what he wants to do. I'll just let him do whatever he wants and focus on providing logistical support."

"This is good, this is good." The leader took a small sip of tea to calm himself down.

The leader is also a medical professor, and he knows very well the difficulties and challenges of vaccine adjuvants. He has talked with many professors in this area, and they have all made a lot of efforts, but there has been no breakthrough for a long time.

I didn't actually intend to assign any tasks today; it was just something I felt compelled to say during our conversation. I didn't expect Yang Ping to immediately take on the task.

That's nothing. Young people, especially geniuses like him, dare to think and act.

But he said that only a few people were needed, and that the research was not difficult. This left the leader a bit confused, unable to process what he was thinking. How could a few people possibly do this?
After leaving Dean Xia's office, Yang Ping didn't rest. He immediately called Tang Shun over to discuss the matter, hoping to select a few people to quickly set up a research group to study vaccine adjuvants. When Tang Shun heard that it was only a few people, he was initially taken aback. How could a few people do it?

So many large companies spent so much time developing only five adjuvants, which shows how difficult adjuvant research is. The preventive medicine industry mainly focuses on various vaccines, and adjuvants are the core technology of vaccines. In fact, the Penang vaccine itself is more difficult to research. Professor Yang dared to start a research project with only a few people.

“I will personally take charge of this project. You just need to find a few capable PhDs for me,” Yang Ping said.

Tang Shun then understood what was going on. Professor Yang was personally taking charge of tackling core technologies for the country's pharmaceutical industry. He didn't intend to put too much pressure on the laboratory or use too many of its resources; he just needed a few people.

Although the lab is currently short-staffed, it shouldn't be a problem to allocate a few more people.

"Professor, are you sure you only need a few people? Would five people be enough for you?" Tang Shun was still a little incredulous.

Yang Ping nodded: "That's enough!"

Tang Shun thought for a moment, mentally calculating how many people the lab could currently utilize. The new staff members weren't deeply involved in the original projects, having only just begun to engage with them. Transferring these people to Professor Yang wouldn't pose any problem and wouldn't affect the operation of the existing projects. His only concern was whether these few people were enough.

Researching vaccine adjuvants is no easy task, but Professor Yang's dedication is another matter entirely; for him, many things cannot be judged by common sense.

After careful consideration, Tang Shun wrote down a list on the spot and handed it to Yang Ping. Yang Ping took the list and looked at it: "Won't removing these five people affect the progress of the original project? Try to give me some new people."

"These are all newcomers, don't worry, they won't affect the original project. If you're not satisfied with these people, just let me know, and I can arrange for them to be transferred," Tang Shun assured him. Five people—it wouldn't affect the lab's operation at all. But could five people really push this project forward? Tang Shun was still a little doubtful. Normally, Professor Yang assigned all projects, big or small, to him and Lu Xiaolu. The two labs together had at least a hundred people, and now there were even more.

Based on Tang Shun's understanding of vaccine adjuvants, let alone a team of five people, even a team of five hundred people would find it difficult to succeed in a short period of time. Luck plays a very important role in adjuvant research. Pharmaceutical giants have a large amount of previous experimental data to support their research, allowing them to stand on the shoulders of giants. Newcomers have no prior data to refer to, making their research extremely difficult and their success rate very low. He really wanted to know if the professor could really develop a new type of medical adjuvant with a team of five.

If the professor really does it, it will be another refresh of our understanding. Constantly having our understanding refreshed is a wonderful thing, as it allows us to maintain a unique sense of novelty towards the world.

Another possibility is that the professor might have set up this research group simply to appease his superiors, which is not in line with his style. He is an honest and straightforward person who never engages in such underhanded tactics.

However, using a team of five to research vaccine adjuvants is a gross underestimation of the difficulty of vaccine adjuvant development; it's too frivolous.

Tang Shun was very efficient. Within 24 hours, he assembled a team of five and educated them about their mission. When they heard that they would be working with Professor Yang on vaccine adjuvant research, they were all immediately energized and full of fighting spirit. They patted their chests and said they would guarantee to complete the mission, just like recruits who had been training for a long time and were eager to make a name for themselves on the battlefield.

But when they heard that the research topic was vaccine adjuvants, they immediately looked at each other in bewilderment. After mentally counting the number of people several times, someone timidly asked, "Is it just the five of us?"

Tang Shun shook his head: "Of course there are more than five people."

The five PhDs immediately perked up. They realized that a large team would be undertaking this arduous task, and the five of them were just a small part of it. They breathed a sigh of relief.

"Who else is there, and when will they be in position?" someone asked, eager to find their main force.

With the capabilities of Sanbo Laboratory, organizing a team of several hundred or even several thousand people should not be difficult. Just imagine being one of those hundreds or thousands of people, working together to tackle the key technologies urgently needed by the country. It is truly a blessing in my life to participate in such a glorious and mission-filled project right after graduation.

Tang Shun nodded slightly: "And Professor Yang, your team currently has six people. Of course, you will be responsible for most of the specific work, while Professor Yang will only be responsible for the planning of the research project."

Professor Yang and only six people? Are you kidding me? Everyone looked at each other in disbelief. What kind of approach is this? Six people researching vaccine adjuvants?

Do you think those pharmaceutical giants are pushovers? Their huge teams spent so much time and money developing only five adjuvants. How could six of us possibly develop adjuvants?

One PhD student recalled with lingering fear the memory of vaccine adjuvants. A pharmaceutical company collaborated with his supervisor, investing tens of millions of yuan and assembling over a hundred people to specialize in vaccine adjuvants, vowing to achieve a breakthrough in this area. However, they later discovered that the difficulties were greater than imagined, and their research capabilities were simply child's play. In the end, all their investment went down the drain, and apart from publishing a few papers, they achieved nothing.

Six people are now researching vaccine adjuvants; it's more like playing house than playing house.